Why is LION listed on the German stock market as well as on ...
back to LION bioscience home
SitemapPrintable version of this documentContact LIONZur deutschen Version dieses Dokuments LION bioscience AG
Investors
Share Information
Financial Figures
Financial Reports
Corporate Governance
Business Model
Press & Ad hoc Releases
Speeches & Presentations
Financial Calendar
FAQs
Why had LION to revise its policy on timing of revenue recognition? What influence does the restatement have on LIONīs Key Figures?
When do the Bayer deals expire?
Why had LION to revise the sales outlook again?
Which steps have been taken to reach profitability?
Why is LION listed on the German stock market as well as on Nasdaq?
What is LION’s business strategy?
When will LION reach profitability? What will the cash position be at that point?
What is an ADR?
Glossary
Info Service
Investor Contact
 

© 2004 LION bioscience AG
Disclaimer
Imprint/Contact
Contact Webmaster
Why is LION listed on the German stock market as well as on Nasdaq?
 

The U.S. is the largest and most important market for biotechnology. LION earns a considerable portion of its revenues in the U.S. and will further strengthen its market position there.